120 related articles for article (PubMed ID: 17074953)
1. Validation of remission criteria for schizophrenia.
van Os J; Drukker M; à Campo J; Meijer J; Bak M; Delespaul P
Am J Psychiatry; 2006 Nov; 163(11):2000-2. PubMed ID: 17074953
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of functional remission in schizophrenic disorder. The FROGS Scale].
Rouillon F; Baylé FJ; Gorwood P; Lancrenon S; Lançon C; Llorca PM;
Encephale; 2013 May; 39 Suppl 1():S15-21. PubMed ID: 23541143
[TBL] [Abstract][Full Text] [Related]
3. One-year functional outcomes of naturalistically treated patients with schizophrenia.
Spellmann I; Riedel M; Schennach R; Seemüller F; Obermeier M; Musil R; Jäger M; Schmauß M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ
Psychiatry Res; 2012 Aug; 198(3):378-85. PubMed ID: 22421065
[TBL] [Abstract][Full Text] [Related]
4. The concurrent and predictive validity of symptomatic remission criteria in first-episode schizophrenia.
Chang WC; Chan TC; Chen ES; Hui CL; Wong GH; Chan SK; Lee EH; Chen EY
Schizophr Res; 2013 Jan; 143(1):107-15. PubMed ID: 23151398
[TBL] [Abstract][Full Text] [Related]
5. Remission in schizophrenia: results from a 1-year follow-up observational study.
Ciudad A; Alvarez E; Bobes J; San L; Polavieja P; Gilaberte I
Schizophr Res; 2009 Mar; 108(1-3):214-22. PubMed ID: 19168329
[TBL] [Abstract][Full Text] [Related]
6. Remission criteria and functional outcome in patients with schizophrenia, a longitudinal study.
Heering HD; Janssens M; Boyette LL; van Haren NE;
Aust N Z J Psychiatry; 2015 Mar; 49(3):266-74. PubMed ID: 25406458
[TBL] [Abstract][Full Text] [Related]
7. The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission.
Henry LP; Amminger GP; Harris MG; Yuen HP; Harrigan SM; Prosser AL; Schwartz OS; Farrelly SE; Herrman H; Jackson HJ; McGorry PD
J Clin Psychiatry; 2010 Jun; 71(6):716-28. PubMed ID: 20573330
[TBL] [Abstract][Full Text] [Related]
8. Validation of a functional remission threshold for the Functional Remission of General Schizophrenia (FROGS) scale.
Boyer L; Richieri R; Guedj E; Faget-Agius C; Loundou A; Llorca PM; Auquier P; Lançon C
Compr Psychiatry; 2013 Oct; 54(7):1016-22. PubMed ID: 23731897
[TBL] [Abstract][Full Text] [Related]
9. Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics.
Wunderink L; Nienhuis FJ; Sytema S; Wiersma D
Schizophr Bull; 2007 May; 33(3):792-6. PubMed ID: 16894026
[TBL] [Abstract][Full Text] [Related]
10. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
[TBL] [Abstract][Full Text] [Related]
11. Unmet needs in patients with first-episode schizophrenia: a longitudinal perspective.
Landolt K; Rössler W; Burns T; Ajdacic-Gross V; Galderisi S; Libiger J; Naber D; Derks EM; Kahn RS; Fleischhacker WW;
Psychol Med; 2012 Jul; 42(7):1461-73. PubMed ID: 22099529
[TBL] [Abstract][Full Text] [Related]
12. Remission in schizophrenia: a community-based 6-year follow-up study in Bali.
Kurihara T; Kato M; Reverger R; Tirta IG
Psychiatry Clin Neurosci; 2011 Aug; 65(5):476-82. PubMed ID: 21851456
[TBL] [Abstract][Full Text] [Related]
13. Symptomatic remission and neurocognitive functioning in patients with schizophrenia.
Hofer A; Bodner T; Kaufmann A; Kemmler G; Mattarei U; Pfaffenberger NM; Rettenbacher MA; Trebo E; Yalcin N; Fleischhacker WW
Psychol Med; 2011 Oct; 41(10):2131-9. PubMed ID: 21426601
[TBL] [Abstract][Full Text] [Related]
14. [Social functioning and quality of life in schizophrenia patients --relationship with symptomatic remission and duration of illness].
Górna K; Jaracz K; Jaracz J; Kiejda J; Grabowska-Fudala B; Rybakowski J
Psychiatr Pol; 2014; 48(2):277-88. PubMed ID: 25016765
[TBL] [Abstract][Full Text] [Related]
15. [Recovery and remission in schizophrenia. Results from a naturalistic 2-year follow-up inpatient study].
Wolter A; Preuss U; Krischke N; Wong JW; Langosch JM; Zimmermann J
Fortschr Neurol Psychiatr; 2010 Aug; 78(8):468-74. PubMed ID: 20694939
[TBL] [Abstract][Full Text] [Related]
16. Relationship of symptomatic remission with quality of life and functionality in patients with schizophrenia.
Karadayi G; Emiroğlu B; Uçok A
Compr Psychiatry; 2011; 52(6):701-7. PubMed ID: 21296345
[TBL] [Abstract][Full Text] [Related]
17. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates.
Brissos S; Dias VV; Carita AI; Martinez-Arán A
Psychiatry Res; 2008 Jul; 160(1):55-62. PubMed ID: 18485488
[TBL] [Abstract][Full Text] [Related]
18. [Self-rating scales in schizophrenia: validity assessment of the Paranoid-Depression Scale (PD-S), the Frankfurt Self-feeling Scale (FBS) and of two visual analogy scales].
Schaeffer E; Wciórka J
Psychiatr Pol; 2003; 37(2):293-314. PubMed ID: 12776660
[TBL] [Abstract][Full Text] [Related]
19. The "Functional Remission of General Schizophrenia" (FROGS) scale: development and validation of a new questionnaire.
Llorca PM; Lançon C; Lancrenon S; Bayle FJ; Caci H; Rouillon F; Gorwood P
Schizophr Res; 2009 Sep; 113(2-3):218-25. PubMed ID: 19464855
[TBL] [Abstract][Full Text] [Related]
20. A prospective, open-label study to evaluate symptomatic remission in schizophrenia with risperidone long-acting injectable in Korea.
Lee NY; Kim SH; Cho SJ; Chung YC; Jung IK; Kim CY; Kim DH; Lee DG; Lee YH; Lim WJ; Na YS; Shin SE; Woo JM; Yoon JS; Yoon BH; Ahn YM; Kim YS
Int Clin Psychopharmacol; 2014 Sep; 29(5):279-87. PubMed ID: 24583566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
